We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
126
Zurich Cantonal Bank
Switzerland
$8.57M +$7.9M +107,267 New
IRF
127
IBM Retirement Fund
New York
$8.4M +$7.75M +105,178 New
N
128
Nuveen
North Carolina
$8.15M +$7.5M +101,849 New
SOMRS
129
State of Michigan Retirement System
Michigan
$8.14M +$7.5M +101,900 New
TA
130
Teton Advisors
New York
$7.97M +$7.33M +99,556 New
ZDA
131
Zweig-DiMenna Associates
New York
$7.91M +$7.28M +98,790 New
ARTA
132
A.R.T. Advisors
New York
$7.85M +$7.22M +98,071 New
BCIM
133
British Columbia Investment Management
British Columbia, Canada
$7.82M +$7.2M +97,725 New
TD Asset Management
134
TD Asset Management
Ontario, Canada
$7.73M +$7.12M +96,726 New
SGA
135
Sector Gamma AS
Norway
$7.63M +$7.02M +95,300 New
EVM
136
Eaton Vance Management
Massachusetts
$7.59M +$7M +95,064 New
RJA
137
Raymond James & Associates
Florida
$7.59M +$6.98M +94,782 New
HCM
138
Highbridge Capital Management
New York
$7.39M +$6.8M +92,337 New
LMGAM
139
Liberty Mutual Group Asset Management
Massachusetts
$7.3M +$6.72M +91,248 New
ILIM
140
Irish Life Investment Managers
Ireland
$7.12M +$6.56M +89,101 New
Alyeska Investment Group
141
Alyeska Investment Group
Illinois
$6.8M +$6.26M +85,000 New
FAF
142
Fjarde Ap-fonden
Sweden
$6.74M +$6.21M +84,377 New
CC
143
Curian Capital
Colorado
$6.68M +$6.15M +83,460 New
ProShare Advisors
144
ProShare Advisors
Maryland
$6.63M +$6.11M +82,960 New
Massachusetts Financial Services
145
Massachusetts Financial Services
Massachusetts
$6.59M +$6.06M +82,340 New
AIM
146
abrdn Investment Management
United Kingdom
$6.36M +$5.86M +79,506 New
Bank of Montreal
147
Bank of Montreal
Ontario, Canada
$5.98M +$5.5M +74,648 New
USAA
148
United Services Automobile Association
Texas
$5.88M +$5.43M +73,682 New
Public Employees Retirement Association of Colorado
149
Public Employees Retirement Association of Colorado
Colorado
$5.64M +$5.2M +70,571 New
CAM
150
ClariVest Asset Management
California
$5.57M +$5.13M +69,727 New
4 5
6
7 8

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.